Pulmatrix Inc
PULM2.280USD
-0.080-3.39%
Close 12/24, 13:00（ET）Quotes delayed by 15 min
8.33MMarket Cap
LossP/E TTM
More Details of Pulmatrix Inc Company
Pulmatrix, Inc. is a biopharmaceutical company. The Company is focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with unmet medical needs using its patented iSPERSE technology. The Company’s proprietary product pipeline includes treatments for central nervous system (CNS) disorders such as acute migraine and serious lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) and allergic bronchopulmonary aspergillosis (ABPA). Pulmatrix’s product candidates are based on its proprietary engineered dry powder delivery platform, iSPERSE, which seeks to enhance therapeutic delivery to the lungs by optimizing pharmacokinetics and reducing systemic side effects to improve patient outcomes. iSPERSE is a proprietary technology that allows a broad range of drugs to be formulated as small, dense, and dispersible particles for efficient drug delivery and deep penetration into the lungs.
Pulmatrix Inc Info
Ticker SymbolPULM
Company namePulmatrix Inc
IPO dateMar 21, 2014
CEOLudlum (Peter B)
Number of employees2
Security typeOrdinary Share
Fiscal year-endMar 21
Address945 Concord Street
CityFRAMINGHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code01701
Phone18883554440
Websitehttps://www.pulmatrix.com/
Ticker SymbolPULM
IPO dateMar 21, 2014
CEOLudlum (Peter B)
Company Executives of Pulmatrix Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Chairman of the Board
Independent Chairman of the Board
7.83K
--
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
Independent Director
Independent Director
4.16K
--
Dr. Christopher H. (Chris) Cabell, M.D.
Dr. Christopher H. (Chris) Cabell, M.D.
Independent Director
Independent Director
4.16K
--
Mr. Anand Varadan
Mr. Anand Varadan
Independent Director
Independent Director
3.32K
--
Mr. Timothy McCarthy
Mr. Timothy McCarthy
Investor Relations
Investor Relations
--
--
Mr. Peter B. Ludlum
Mr. Peter B. Ludlum
Interim Chief Executive Officer and Interim Chief Financial Officer
Interim Chief Executive Officer and Interim Chief Financial Officer
--
--
Dr. Richard Batycky, Ph.D.
Dr. Richard Batycky, Ph.D.
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Michael J. Higgins
Mr. Michael J. Higgins
Independent Chairman of the Board
Independent Chairman of the Board
7.83K
--
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
Independent Director
Independent Director
4.16K
--
Dr. Christopher H. (Chris) Cabell, M.D.
Dr. Christopher H. (Chris) Cabell, M.D.
Independent Director
Independent Director
4.16K
--
Mr. Anand Varadan
Mr. Anand Varadan
Independent Director
Independent Director
3.32K
--
Mr. Timothy McCarthy
Mr. Timothy McCarthy
Investor Relations
Investor Relations
--
--
Mr. Peter B. Ludlum
Mr. Peter B. Ludlum
Interim Chief Executive Officer and Interim Chief Financial Officer
Interim Chief Executive Officer and Interim Chief Financial Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Nov 14
Updated: Fri, Nov 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
3.13%
SBI Securities Co., Ltd.
1.62%
BlackRock Institutional Trust Company, N.A.
1.52%
The Vanguard Group, Inc.
1.35%
Geode Capital Management, L.L.C.
1.12%
Other
91.25%
Shareholders
Shareholders
Proportion
Renaissance Technologies LLC
3.13%
SBI Securities Co., Ltd.
1.62%
BlackRock Institutional Trust Company, N.A.
1.52%
The Vanguard Group, Inc.
1.35%
Geode Capital Management, L.L.C.
1.12%
Other
91.25%
Shareholder Types
Shareholders
Proportion
Hedge Fund
3.17%
Investment Advisor
2.87%
Investment Advisor/Hedge Fund
1.80%
Research Firm
1.63%
Individual Investor
0.66%
Other
89.87%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
26
343.59K
9.41%
-66.34K
2025Q2
32
356.36K
9.76%
-74.96K
2025Q1
34
346.08K
9.48%
-117.47K
2024Q4
30
329.25K
9.01%
-61.75K
2024Q3
31
276.56K
7.57%
-108.94K
2024Q2
31
263.58K
7.22%
-1.04M
2024Q1
33
261.48K
7.16%
-1.04M
2023Q4
39
316.17K
8.66%
-1.16M
2023Q3
44
516.38K
14.50%
-1.18M
2023Q2
48
580.98K
16.42%
-1.18M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Renaissance Technologies LLC
110.82K
3.03%
+1.90K
+1.74%
Jun 30, 2025
SBI Securities Co., Ltd.
60.56K
1.66%
+8.21K
+15.68%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
55.34K
1.52%
+436.00
+0.79%
Jun 30, 2025
The Vanguard Group, Inc.
47.01K
1.29%
+4.61K
+10.87%
Jun 30, 2025
Geode Capital Management, L.L.C.
41.08K
1.12%
+716.00
+1.77%
Jun 30, 2025
State Street Investment Management (US)
13.95K
0.38%
--
--
Jun 30, 2025
Dimensional Fund Advisors, L.P.
6.25K
0.17%
--
--
Aug 31, 2025
Higgins (Michael J)
7.83K
0.21%
--
--
May 01, 2025
Batycky (Richard P. Ph.D.)
4.69K
0.13%
--
--
May 01, 2025
Bazemore (Todd M)
4.16K
0.11%
--
--
May 01, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
DFA Dimensional US Sustainability Core 1 ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
Date
Type
Ratio
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
Feb 25, 2022
Merger
20→1
FAQs
Who are the top five shareholders of Pulmatrix Inc?
The top five shareholders of Pulmatrix Inc are:
Renaissance Technologies LLC holds 110.82K shares, accounting for 3.03% of the total shares.
SBI Securities Co., Ltd. holds 60.56K shares, accounting for 1.66% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 55.34K shares, accounting for 1.52% of the total shares.
The Vanguard Group, Inc. holds 47.01K shares, accounting for 1.29% of the total shares.
Geode Capital Management, L.L.C. holds 41.08K shares, accounting for 1.12% of the total shares.
Renaissance Technologies LLC holds 110.82K shares, accounting for 3.03% of the total shares.
SBI Securities Co., Ltd. holds 60.56K shares, accounting for 1.66% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 55.34K shares, accounting for 1.52% of the total shares.
The Vanguard Group, Inc. holds 47.01K shares, accounting for 1.29% of the total shares.
Geode Capital Management, L.L.C. holds 41.08K shares, accounting for 1.12% of the total shares.
What are the top three shareholder types of Pulmatrix Inc?
The top three shareholder types of Pulmatrix Inc are:
Renaissance Technologies LLC
SBI Securities Co., Ltd.
BlackRock Institutional Trust Company, N.A.
Renaissance Technologies LLC
SBI Securities Co., Ltd.
BlackRock Institutional Trust Company, N.A.
How many institutions hold shares of Pulmatrix Inc (PULM)?
As of 2025Q3, 26 institutions hold shares of Pulmatrix Inc, with a combined market value of approximately 343.59K, accounting for 9.41% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -0.35%.
What is the biggest source of revenue for Pulmatrix Inc?
In --, the -- business generated the highest revenue for Pulmatrix Inc, amounting to -- and accounting for --% of total revenue.
